Brief Report: The Immune Profiles of the Molecular Subtypes of EGFR-Mutant Lung Adenocarcinomas in a Large Real-World Cohort.

Competing Interests: Disclosure JN Bodor reports speaker honoraria from MJH Life Sciences and Association of Community Cancer Centers (ACCC), advisory roles with Bayer and National Association for Continuing Education (NACE). J Xiu reports employment with Caris Life Sciences. V Ernani reports advisory roles with Astra Zeneca, Daiichi Sankyo, Pfizer, Bayer, Jazz Pharmaceuticals, Novocure, BioAtla. S Kaur reports speaker honoraria from Eli Lilly. H Mamdani reports advisory roles with AstraZeneca, Genentech, Zentalis, Daiichi Sankyo, institution research support from AstraZeneca. SI Ou reports consulting roles with AnHeart Therapeutics, Pfizer, Janssen, Daiichi Sankyo, BMS, Merus; speaker honoraria from Pfizer, Janssen, DAVA Oncology LLP, OncLive, Caris Life Science; advisory roles with Elevation Oncology, AnHeart Therapeutics; stock/stock options with MBrace Therapeutics, Blossom Hill Therapeutics, Elevation Oncology, Turning Point Therapeutics; research funding to institution from Pfizer, Janssen, Nuvalent, Mirati, Revolution Medicine, Merus, Daiichi Sankyo, Erasca, Merck. H. Borghaei reports research support from BMS, Lilly, Amgen; consultant roles with BMS, Lilly, Genentech, Pfizer, Merck, EMD-Serono, Boehringer Ingelheim, Astra Zeneca, Novartis, Genmab, Regeneron, BioNTech, Amgen, Axiom, PharmaMar, Takeda, Mirati, Daiichi, Guardant, Natera, Oncocyte, Beigene, iTEO , Jazz, Janssen, Puma, BerGenBio, Bayer, Iobiotech, Grid Therapeutics, RAPT; Data and Safety Monitoring Board: University of Pennsylvania CAR T Program, Takeda, Incyte, Novartis, Springworks Employment; Fox Chase Cancer Center Scientific Advisory Board; Sonnetbio (Stock Options); Inspirna (formerly Rgenix, stock options); Nucleai (stock options); honoraria from Amgen, Pfizer, Daiichi, Regeneron; Travel support from Amgen, BMS, Merck, Lilly, EMDSerono, Genentech, Regeneron, Mirati. A Vanderwadle reports employment with Caris Life Sciences. The remaining authors have no conflicts of interest.